American International Group’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

American International Group’s Portfolio CADX Stock Details CADX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-41,937	Closed	-$380K	–	4942
2013 Q4	$380K	Sell	41,937 -412	-1%	-$2.98K	﹤0.01%	2232
2013 Q3	$267K	Sell	42,349 -68	-0.2%	-$432	﹤0.01%	2475
2013 Q2	$289K	Buy	+42,417	New	+$295K	﹤0.01%	2257

Other funds holding CADX

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American International Group's CADX Position: Q1 2014 in Review

American International Group sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 41,937 shares — an estimated $380K sold.

American International Group first reported a position in CADX in Q2 2013 and held it in 3 quarters. The position peaked at $380K in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

American International Group reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
American International Group sold 41,937 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $380K.
American International Group first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 3 quarters.
American International Group's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $380K in Q4 2013.
3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on American International Group's 13F filing for Q1 2014, filed 12 May 2014.